Ghost Tree Capital, LLC - Q3 2018 holdings

$470 Million is the total value of Ghost Tree Capital, LLC's 55 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 100.0% .

 Value Shares↓ Weighting
BHVN ExitBIOHAVEN PHARMACTL HLDG CO Lcall$0-2,000
-100.0%
-0.04%
LCI ExitLANNET INCcall$0-2,000
-100.0%
-0.15%
PBYI ExitPUMA BIOTECHNOLOGY INC$0-14,000
-100.0%
-0.24%
ACOR ExitACORDA THERAPEUTICS INC$0-33,000
-100.0%
-0.28%
LCI ExitLANNET INC$0-250,000
-100.0%
-1.00%
IOVA ExitIOVANCE BIOTHERAPEUTICS INC$0-360,000
-100.0%
-1.36%
BOLD ExitAUDENTES THERAPEUTICS INC$0-125,000
-100.0%
-1.41%
AVRO ExitAVROBIO INC$0-230,000
-100.0%
-1.93%
ADMS ExitADAMAS PHARMACEUTICALS INC$0-295,000
-100.0%
-2.24%
EXEL ExitEXELIXIS INC$0-400,000
-100.0%
-2.53%
ARWR ExitARROWHEAD PHARMACEUTICALS IN$0-700,000
-100.0%
-2.80%
MRSN ExitMERSANA THERAPEUTICS INC$0-600,000
-100.0%
-3.15%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2020-04-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MIRATI THERAPEUTICS INC30Q3 20237.3%
ASCENDIS PHARMA A/S - ADR28Q3 202311.8%
BIOCRYST PHARMACEUTICALS INC25Q2 20232.4%
AMICUS THERAPEUTICS INC23Q3 20235.6%
SAREPTA THERAPEUTICS INC22Q3 20239.1%
SPDR SER TR20Q3 202216.9%
IOVANCE BIOTHERAPEUTICS INC18Q2 20235.5%
ROCKET PHARMACEUTICALS INC18Q2 20236.1%
SAGE THERAPEUTICS INC18Q1 20214.8%
IMMUNOMEDICS INC17Q2 20208.7%

View Ghost Tree Capital, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-16

View Ghost Tree Capital, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Ghost Tree Capital, LLC's holdings